Coordinated expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 during corpus luteum formation and luteolysis in the adult pseudopregnant rat

Endocrinology

Volumn 137, Issue 5, 1996, Pages 2126-2132

  Liu, Kui ^a,b   Brändström, Anna ^a   Liu, Yi Xun ^b   Ny, Tor ^a   Selstam, Gunnar ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b INSTITUTE OF ZOOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CORPUS LUTEUM FUNCTION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; LUTEOLYSIS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

EID: 0029971772     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.5.8612557     Document Type: Article

References (36)

1. Dano K, Andreasen PA, Grondahl Hansen J, Kristensen P, Nielsen LS, Skriver L 1985 Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44:139-266
2. Saksela O, Rifkin DB 1988 Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol 4:93-126
3. Vassalli JD, Sappino AP, Belin D 1991 The plasminogen activator/ plasmin system. J Clin Invest 88:1067-1072
4. Loskutoff DJ 1988 Type 1 plasminogen activator inhibitor and its potential influence on thrombolytic therapy. Semin Thromb Hemost 14:100-109
5. Andreasen PA, Georg B, Lund LR, Riccio A, Stacey SN 1990 Plasminogen activator inhibitors: hormonally regulated serpins. Mol Cell Endocrinol 68:1-19
6. Beers WH 1975 Follicular plasminogen and plasminogen activator and the effect of plasrnin on ovarian follicle wall. Cell 6:379-386
7. Liu YX, Peng XR, Ny T 1991 Tissue-specific and time-coordinated hormone regulation of plasminogen-activator-inhibitor type I and tissue-type plasminogen activator in the rat ovary during gonadotropin-induced ovulation. Eur J Biochem 195:549-555
8. Peng XR, Hsueh AJ, Ny T 1993 Transient and cell-specific expression of tissue-type plasminogen activator and plasminogen-activator-inhibitor type 1 results in controlled and directed proteolysis during gonadotropin-induced ovulation. Eur J Biochem 214:147-156
9. Leonardsson G, Peng XR, Liu K, Nordstrom L, Carmeliet P, Mulligan R, Collen D, Ny T 1995 Ovulation efficiency is reduced in mice that lack plasminogen activator gene function: functional redundancy among physiological plasminogen activators. Proc Natl Acad Sci USA 92:12446-12450
10. Niswender GD, Nett TM 1995 The corpus luteum and its control in infraprimate species. In: Knobil E, Neill JD (eds) The Physiology of Reproduction. Raven Press, New York, pp 781-816
11. Findlay JK 1986 Angiogenesis in reproductive tissues. J Endocrinol 111:357-366
12. Auletta FJ, Flint APF 1988 Mechanisms controlling corpus luteum function in sheep, cows, nonhuman primates, and women especially in relation to the time of luteolysis. Endocr Rev 9:88-105
13. Michael AE, Abayasekara DRE, Webley GE 1994 Cellular mechanisms of luteolysis. Mol Cell Endocrinol 99:R1-R9
14. Pate JL 1994 Cellular components involved in luteolysis. J Anim Sci 72:1884-1890
15. Selstam G, Gafvels M, Norjavaara E, Damber JE 1985 Acute increase of noradrenaline on vascular resistance in the corpus luteum of the pseudopregnant rat. J Reprod Fertil 75:351-356
16. Gafvels M, Bjurulf E, Selstam G 1992 Prolactin stimulates the expression of luteinizing hormone/chorionic gonadotropin receptor messenger ribonucleic acid in the rat corpus luteum and rescues early pregnancy from bromocriptine-induced abortion. Biol Reprod 47:534-540
17. Gafvels M, Selstam G, Damber JE 1987 Influence of oxygen tension and substrates on basal and luteinizing hormone stimulated progesterone production and energy metabolism by isolated corpora lutea of adult pseudopregnant rats. Acta Physiol Scand 130:475-482
18. Norjavaara E, Olofsson J, Gafvels M, Selstam G 1987 Redistribution of ovarian blood flow after injection of human chorionic gonadotropin and luteinizing hormone in the adult pseudopregnant rat. Endocrinology 120:107-114
19. Peng XR, Hsueh AJ, LaPolt PS, Bjersing L, Ny T 1991 Localization of luteinizing hormone receptor messenger ribonucleic acid expression in ovarian cell types during follicle development and ovulation. Endocrinology 129:3200-3207
20. Schaeren-Wiemers N, Gerfin-Moser A 1993 A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: in situ hybridization using digoxigeninlabelled cRNA probes. Histochemistry 100:431-440
21. Laemmli U 1970 Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature 227:680-685
22. Ny T, Bjersing L, Hsueh AJ, Loskutoff DJ 1985 Cultured granulosa cells produce two plasminogen activators and an antiactivator, each regulated differently by gonadotropins. Endocrinology 116:1666-1668
23. Sappino AP, Huarte J, Vassalli JD, Belin D 1991 Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney. J Clin Invest 87:962-970
24. Vassalli JD, Belin D 1987 Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett 214:187-191
25. Canipari R, O'Connell ML, Meyer G, Strickland S 1987 Mouse ovarian granulosa cells produce urokinase-type plasminogen activator, whereas the corresponding rat cells produce tissue-type plasminogen activator. J Cell Biol 105:977-981
26. Espey LL 1975 Evaluation of proteolytic activity in mammalian ovulation. In: Reich E, Rifkin DB, Shaw E (eds) Proteases and Biological Control. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 767-776
27. Bacharach E, Itin A, Keshet E 1992 In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc Natl Acad Sci USA 89: 10686-10690
28. Saksela O, Moscatelli D, Rifkin DB 1987 The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol 105:957-963
29. Mignatti P, Tsuboi R, Robbins E, Rifkin DB 1989 In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol 108:671-682
30. Pepper MS, Belin D, Montesano R, Orci L, Vassalli JD 1990 Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol 111:743-755
31. Liotta LA, Steeg PS, Stetler Stevenson WG 1991 Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64:327-336
32. Liu YX, Chen YX, Shi FW, Feng Q 1995 Studies on the role of plasminogen activators and plasminogen activator inhibitor type-1 in rat corpus luteum of pregnancy. Biol Reprod 53:1131-1138
33. Feng Q, Liu K, Hu Z, Zou R, Yang SC, Liu Y 1993 The possible involvement of tissue type plasminogen activator in luteolysis of rhesus monkey. Hum Reprod 8:1640-1644
34. Smith GW, Goetz TL, Anthony RV, Smith MF 1994 Molecular cloning of an ovine ovarian tissue inhibitor of metalloproteinases: ontogeny of messenger ribonucleic acid expression and in situ localization within preovulatory follicles and luteal tissue. Endocrinology 134:344-352
35. Endo T, Aten RF, Wang F, Behrman HR 1993 Coordinate induction and activation of metalloproteinase and ascorbate depletion in structural luteolysis. Endocrinology 133:690-698
36. 2-macroglobulin in rat ovarian follicles and corpora lutea. Endocrinology 125:2985-2995